SUPN
NASDAQ · Pharmaceuticals
Supernus Pharmaceuticals Inc
$51.53
-0.75 (-1.43%)
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+76.3% upside
Low Target
$64.19
Average Target
$90.83
High Target
$118.96
Current Price
$51.53
Current
$51.53
$51.53
Target
$90.83
$90.83
$64.19
$90.83 avg
$118.96
Scenario Analysis
Bear Case
$64.19
24.6%
Low target
Base Case
$90.83
+76.3%
Avg target
Bull Case
$118.96
+130.9%
High target
Risk/Reward
5.3x
Highly favorable
Price in Context
52-Week High
$59.68
-13.7% from high
52-Week Low
$29.16
+76.7% from low
50-Day SMA
$49.76
+3.6% vs SMA
200-Day SMA
$43.00
+19.8% vs SMA
RSI (14)
59.9
Neutral
Target vs 52W High
$90.83
+52.2% vs high
Next Earnings Report
May 12, 2026
1d
tomorrow
EPS Est: $0.50
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals